Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001278260 | SCV002202049 | uncertain significance | Methylmalonic aciduria, cblA type | 2021-12-24 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 275 of the MMAA protein (p.Ile275Thr). This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with MMAA-related conditions. ClinVar contains an entry for this variant (Variation ID: 990274). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MMAA protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV001278260 | SCV005662991 | uncertain significance | Methylmalonic aciduria, cblA type | 2024-04-18 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001278260 | SCV001465258 | uncertain significance | Methylmalonic aciduria, cblA type | 2020-09-14 | no assertion criteria provided | clinical testing |